Semrad, Thomas J. http://orcid.org/0000-0002-7810-5887
Kim, Edward J.
Gong, I-Yeh
Li, Tianhong
Christensen, Scott
Arora, Mili
Riess, Jonathan W.
Gandara, David R.
Kelly, Karen
Funding for this research was provided by:
Takeda Pharmaceuticals U.S.A.
National Cancer Institute (P30CA093373, K12CA138464)
Article History
Received: 22 February 2021
Accepted: 3 May 2021
First Online: 15 May 2021
Declarations
:
: Dr. Semrad reports grants (to the University of California, Davis for conduct of this study) from Millennium Pharmaceuticals, Inc.; Dr. Kim reports personal fees from Eisai, personal fees from Celgene, grants from BMS, grants from Astellas, grants from Samumed, grants from Boston Biomedical, grants from Halozyme, grants from EpicentRx, grants from Merck, grants from Oncomed, grants from Dynavax, personal fees from Lilly, grants from NGM Biopharmaceuticals, grants from Erytech, grants from Fibrogen, grants from Eureka Therapeutics, outside the submitted work; Dr. Gong has nothing to disclose; Dr. Li reports personal fees from Eisai, grants from Pfizer, grants from Merck, grants from Eureka, grants from OncoImmune (OncoC4), grants from Hengrui, grants from Tempus, outside the submitted work; Dr. Christensen has nothing to disclose; Dr. Arora has nothing to disclose; Dr. Riess reports personal fees from Blueprint, personal fees and non-financial support from Novartis, personal fees and non-financial support from Boehringer Ingelheim, personal fees from Celgene, non-financial support from AstraZeneca, personal fees and non-financial support from Spectrum, personal fees from Loxo Oncology, personal fees from Genentech, personal fees from Medtronic, non-financial support from Merck, non-financial support from Revolution Medicines, outside the submitted work; Dr. Gandara has nothing to disclose; Dr. Kelly reports grants and personal fees from Takeda.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study protocol was reviewed and approved by the institutional review board of the University of California, Davis.
: All patients provided written informed consent before treatment.
: All authors consent to publication.